0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Hepatology

Buy Now

Hepatitis C Virus: The Next Epidemic, An issue of Gastroenterology Clinics of North America, Volume 44-4 (Hardcover) Loot Price: R1,693
Discovery Miles 16 930
Hepatitis C Virus: The Next Epidemic, An issue of Gastroenterology Clinics of North America, Volume 44-4 (Hardcover): K....

Hepatitis C Virus: The Next Epidemic, An issue of Gastroenterology Clinics of North America, Volume 44-4 (Hardcover)

K. Rajender Reddy

Series: The Clinics: Internal Medicine

 (sign in to rate)
Loot Price R1,693 Discovery Miles 16 930 | Repayment Terms: R159 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

There are over 180 million people with chronic HCV infection worldwide with between 2.7 and 3.9 million in the United States. Hepatitis C most significantly affects Asia and Africa, with rates up to 15% in countries such as Egypt and up to 30% in certain regions such as Punjab, Pakistan. Hepatitis C places a significant burden on the public health infrastructure, as it remains the leading cause of chronic liver disease, accounting for 50-75% of primary liver cancers and is responsible for 30% of all liver transplantations. It is estimated to have cost the United States $5.5 billion in 1997, comparable to the national cost of asthma, $5.8 billion in 1994.This number is only expected to grow as the current HCV population ages, increasing overall rates of compensated cirrhosis/end-stage liver disease. The evolution of directly acting anti-virals has ushered in a new era for chronic hepatitis C. Ongoing drug development strategy has involved targeting several replication steps of the virus and the hope is to see all oral therapies by late 2014 or early 2015. Thus we are at an exciting cross roads with regard to new information and challenges with HCV: rising disease burden with associated high costs, the challenges globally and in multiple patient populations, and the impending availability of effective and well tolerated treatments. Therefore there is a need to commission an exclusive issue of GCNA for HCV.

General

Imprint: Elsevier - Health Sciences Division
Country of origin: United States
Series: The Clinics: Internal Medicine
Release date: December 2015
Authors: K. Rajender Reddy
Format: Hardcover
ISBN-13: 978-0-323-40248-4
Categories: Books > Medicine > Clinical & internal medicine > Hepatology
Promotions
LSN: 0-323-40248-8
Barcode: 9780323402484

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Drug Hepatotoxicity, An Issue of Clinics…
Vinod Rustgi Hardcover R2,133 Discovery Miles 21 330
Advances in Cholestatic Liver Diseases…
Cynthia Levy Hardcover R1,692 Discovery Miles 16 920
Drug-Induced Liver Injury, Volume 85
Anup Ramachandran, Hartmut Jaeschke Hardcover R5,477 Discovery Miles 54 770
Liver Cirrhosis - Debates and Current…
Georgios Tsoulfas Hardcover R3,077 Discovery Miles 30 770
Hepatitis A and Other Associated…
Costin Teodor Streba, Cristin Constantin Vere, … Hardcover R3,067 Discovery Miles 30 670
Liver Research and Clinical Management
Luis Rodrigo Hardcover R3,101 Discovery Miles 31 010
Causes, Prevention and Management of…
Daisy Truman Hardcover R3,279 R2,969 Discovery Miles 29 690
Liver Diseases: Clinical Management
Tucker Banks Hardcover R3,037 R2,752 Discovery Miles 27 520
Diagnosis and Treatment of Liver…
Finley Bush Hardcover R3,292 R2,982 Discovery Miles 29 820
Handbook of Hepatology
Dinah Beck Hardcover R3,167 R2,870 Discovery Miles 28 700
Diagnosis and Management of Chronic…
Heidi Hamlin Hardcover R3,095 R2,810 Discovery Miles 28 100
Nonalcoholic Fatty Liver Disease - An…
Emad Hamdy Gad Hardcover R3,065 Discovery Miles 30 650

See more

Partners